| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9883 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.5981 |
| P-glycoprotein Substrate | Non-substrate | 0.5955 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6556 |
| Non-inhibitor | 0.9038 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7358 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6652 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7697 |
| CYP450 2D6 Substrate | Substrate | 0.5471 |
| CYP450 3A4 Substrate | Substrate | 0.6147 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5393 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6574 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6844 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.5716 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8361 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6176 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9208 |
| Non-inhibitor | 0.5440 |
| AMES Toxicity | Non AMES toxic | 0.7091 |
| Carcinogens | Non-carcinogens | 0.8437 |
| Fish Toxicity | High FHMT | 0.9559 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9593 |
| Honey Bee Toxicity | Low HBT | 0.7333 |
| Biodegradation | Not ready biodegradable | 0.9898 |
| Acute Oral Toxicity | III | 0.6199 |
| Carcinogenicity (Three-class) | Non-required | 0.5785 |